Shanghai Pharmaceuticals Holding Co Ltd embodies a set of values and a corporate philosophy that underpin its operations. The company believes in delivering high-quality healthcare products and services to meet the evolving needs of its customers. Shanghai Pharmaceuticals focuses on fostering innovation, maintaining integrity, and ensuring sustainable development. By prioritizing the well-being of patients and healthcare professionals, the company strives to enhance public health and contribute to society. Shanghai Pharmaceuticals' commitment to improving medical access and advancing healthcare systems reflects its dedication to delivering value and making a positive impact in the pharmaceutical industry.

Shanghai Pharmaceuticals Holding Co Ltd operates primarily in China. As a leading pharmaceutical company based in Shanghai, China, it has established a strong presence in its home country. With an extensive network and many subsidiaries across China, Shanghai Pharmaceuticals Holding Co Ltd serves a vast market within the country. Its presence and influence in the Chinese pharmaceutical industry contribute to its position as a key player in the region.

Shanghai Pharmaceuticals Holding Co Ltd has achieved several significant milestones in its corporate history. The company has successfully established itself as a leading player in the pharmaceutical sector in China. Shanghai Pharmaceuticals Holding Co Ltd has expanded its business operations both domestically and internationally, through strategic acquisitions and partnerships. The company has demonstrated continued growth and stability, with a diversified product portfolio and a strong presence in key therapeutic areas. Shanghai Pharmaceuticals Holding Co Ltd has consistently focused on innovation, research and development, and delivering high-quality healthcare products and services. Through its continuous efforts, the company has garnered recognition and trust from both investors and consumers alike.

Shanghai Pharmaceuticals Holding Co Ltd, established in 1994, is a renowned Chinese pharmaceutical company. With its headquarters in Shanghai, the company has a rich history and exceptional background in the healthcare industry. Shanghai Pharmaceuticals operates across various segments, including the production, distribution, and retail of pharmaceutical and healthcare products. Over the years, it has expanded its business both domestically and internationally, becoming a leading player in China's pharmaceutical market. With a strong focus on research and development, Shanghai Pharmaceuticals has established strategic partnerships and collaborations with global pharmaceutical giants, further enhancing its position in the industry. This company's commitment to innovation, quality, and customer satisfaction has contributed to its success and widespread recognition.

Some of the main competitors of Shanghai Pharmaceuticals Holding Co Ltd in the market include China Resources Pharmaceutical Group Limited, Jiangsu Hengrui Medicine Co Ltd, and Sinopharm Group Co Ltd.

Shanghai Pharmaceuticals Holding Co Ltd is primarily active in the pharmaceutical industry. As one of the leading pharmaceutical companies in China, it operates in various sectors including research and development, manufacturing, distribution, and retail. With a diversified product portfolio, Shanghai Pharmaceuticals caters to a wide range of healthcare needs, including prescription drugs, over-the-counter medications, traditional Chinese medicine, medical devices, and healthcare services. The company's strong presence and expertise in the pharmaceutical industry enable it to contribute significantly to the advancement of healthcare and improve the quality of life for individuals across China and beyond.

The business model of Shanghai Pharmaceuticals Holding Co Ltd is focused on pharmaceutical production, distribution, and retail sales. As one of China's leading integrated pharmaceutical companies, Shanghai Pharmaceuticals engages in research and development, manufacturing, marketing, and sales of both innovative and generic drugs. The company operates a comprehensive supply chain, including procurement, distribution, and retailing services. By combining its strong domestic presence with international expansion, Shanghai Pharmaceuticals aims to deliver high quality and affordable healthcare products to improve public health in China and beyond.

مُعامل القيمة السوقية إلى الأرباح لـ Shanghai Pharmaceuticals Holding Co هو ٢٩٫٦٤.

مُعامِل القيمة إلى المبيعات Shanghai Pharmaceuticals Holding Co هو ٠٫٢٨.

نقاط جودة AlleAktien لـ Shanghai Pharmaceuticals Holding Co هي 7/10.

المتوقعة Shanghai Pharmaceuticals Holding Co الإيرادات هي ٢٨٤٫٣١ مليارات CNY.

صافي الربح المتوقعة Shanghai Pharmaceuticals Holding Co هو ٢٫٦٤ مليارات CNY.

Shanghai Pharmaceuticals Holding Co Ltd is a leading Chinese pharmaceutical conglomerate that was founded in 1994. The company is headquartered in Shanghai and consists of various divisions, including pharmaceutical manufacturing, medication distribution, research and development, and chemical production. The company offers a wide range of products that are used in various fields of medicine. This includes antidepressants, analgesics, antipyretics, cardiology, and oncology. Additionally, the company also provides traditional Chinese medicine products and medical accessories. The pharmaceutical production division is one of the most important for the company. Here, Shanghai Pharmaceuticals produces a wide range of pharmaceuticals, including generics and patented products. The company has a strong research and development department specialized in producing highly effective drugs for various medical conditions. Another important area for the company is medication distribution. The company has a network of distribution partners that help distribute the products to different countries and regions. Shanghai Pharmaceuticals has branches in many countries and regions, including Thailand, Australia, and the USA. The company also has a strong presence in traditional Chinese medicine and offers a variety of products, including herbal blends and herbal capsules. These products have been used in Chinese culture for thousands of years and are popular among people worldwide. Shanghai Pharmaceuticals also has its own research and development department that is involved in the development of some very important drugs. The company specializes in developing drugs for chronic diseases such as diabetes, cancer, and cardiovascular diseases. In addition to pharmaceutical production, the company also offers some chemical products. Shanghai Pharmaceuticals manufactures various chemicals such as intermediates used in the pharmaceutical industry. These products are often used as raw materials for drug manufacturing. Overall, Shanghai Pharmaceuticals' business model is very successful, and the company is one of the leading Chinese companies in the pharmaceutical industry. The company has established itself as a reliable partner for various medical products and services, and is expected to continue growing in the future.

يوزع Shanghai Pharmaceuticals Holding Co أرباحًا قدرها ٠٫٤٢ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Shanghai Pharmaceuticals Holding Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـShanghai Pharmaceuticals Holding Co هو CNE000000C82.

الرمز المُختصر لـ Shanghai Pharmaceuticals Holding Co هو 601607.SS.

خلال آخر 12 شهراً، دفعت Shanghai Pharmaceuticals Holding Co توزيعات أرباح بقيمة ٠٫٦١ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٢٫٨٨ %. ومن المتوقع أن تدفع Shanghai Pharmaceuticals Holding Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٦٥ CNY.

نسبة توزيعات الأرباح الحالية لـ Shanghai Pharmaceuticals Holding Co هي ٢٫٨٨ %.

Shanghai Pharmaceuticals Holding Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أغسطس, أغسطس, أغسطس, أكتوبر.

Shanghai Pharmaceuticals Holding Co دفعت توزيعات الأرباح كل عام خلال الـ19 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٦٥ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٣٫٠٦ %.

Shanghai Pharmaceuticals Holding Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠٨ CNY من Shanghai Pharmaceuticals Holding Co المُعلن عنها في ٢٤‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٤‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٤‏/٩‏/٢٠٢٤.

في العام 2023، وزعت Shanghai Pharmaceuticals Holding Co ٠٫٤٢ CNY كأرباح أسهم.

يتم توزيع أرباح Shanghai Pharmaceuticals Holding Co بالعملة CNY.